---
title: "Revolution Medicines (RVMD.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/RVMD.US/norm.md"
symbol: "RVMD.US"
name: "Revolution Medicines"
parent: "https://longbridge.com/zh-CN/quote/RVMD.US.md"
datetime: "2026-05-20T01:49:54.890Z"
locales:
  - [en](https://longbridge.com/en/quote/RVMD.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RVMD.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RVMD.US/norm.md)
---

# Revolution Medicines (RVMD.US) — 财务报表

## 利润表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | -2.29 | -1.86 | -1.61 | -1.31 | -1.13 |
| ROE | -115.95% | -90.43% | -70.52% | -50.27% | -39.31% |
| 营业收入 | - | - | - | - | - |
| 净利润 | -453.82M | -364.89M | -305.21M | -247.79M | -213.42M |
| 营业利润 | -445.22M | -361.63M | -315.27M | -264.71M | -240.76M |
| 毛利率 | - | - | - | - | - |
| 净利率 | - | - | - | - | - |
| 利润含金量 | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 资产与负债 | 2.25B | 2.35B | 2.25B | 2.43B | 2.37B |
| 权益乘数 | 1.50 | 1.44 | 1.41 | 1.30 | 1.14 |
| 每股净资产 | 7.49 | 8.28 | 8.42 | 9.98 | 11.16 |
| 资产周转率 | - | - | - | - | - |
| 现金及短投 | 1.91B | 2.03B | 1.93B | 2.14B | 2.10B |
| 存货与应收 | - | - | - | - | - |
| 长期投资 | 161.37M | 165.28M | 167.38M | 147.05M | 142.93M |
| 净债务 | -1.47B | -1.60B | -1.52B | -1.76B | -1.97B |

## 现金流量表 (USD)

| 指标 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| 经营现金流 | -354.17M | -274.24M | -207.31M | -221.76M | -194.44M |
| 投资现金流 | 172.62M | 74.88M | 24.85M | 34.28M | -15.95M |
| 融资现金流 | 238.74M | 365.66M | -1.59M | 256.58M | 874000.00 |
| 自由现金流 | -199.41M | -148.26M | -114.14M | -121.80M | -123.94M |
| 现金流充裕率 | -23027.63% | -14246.13% | -6190.24% | -2976.60% | -5953.31% |
| 举债与偿债 | - | - | - | - | - |
| 资本支出 | -1.54M | -1.93M | -3.35M | -7.45M | -3.27M |